Generated automatically from the NAFDAC register, WHO alerts and community data as of today. This is not medical advice. Always follow your doctor or pharmacist.
From the official U.S. FDA label for brimonidine tartrate, the active ingredient registered with NAFDAC.
relieves redness of the eye due to minor eye irritations
Redness reliever
if solution changes color or becomes cloudy
For external use only Do not use if solution changes color or becomes cloudy Stop use and ask a doctor if you experience eye pain, changes in vision, continued redness or irritation of the eye condition worsens or persists for more than 3 days If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
If pregnant or breast-feeding, ask a health professional before use.
Compare the brands and batch numbers in these notices with your pack, or enter your batch number above.
Add the expiry date on your pack for a full Trust Score.
NCI Brimonidine Eye Drops_ contains Brimonidine Tartrate (0.1%), as eye drops, according to its NAFDAC registration record.
Yes. NCI Brimonidine Eye Drops_ is listed on the NAFDAC register under registration number C4-1722, and its registration is active as of 27 October 2026.
No WHO falsified or substandard medical product alert currently matches NCI Brimonidine Eye Drops_ in our automatically synced alert list.
Run a free authenticity scan with the NAFDAC number C4-1722, your pack's expiry date and batch number to get a Trust Score, compare the pack with the NAFDAC record (ingredient, strength, form, manufacturer), and buy only from licensed pharmacies.
relieves redness of the eye due to minor eye irritations (Summarised from the official U.S. FDA label for brimonidine tartrate. Always follow your doctor or pharmacist.)
Reviews are personal experiences from PillVera users, not medical advice. Report side effects to your doctor and to NAFDAC.